Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Social and economic value of Portuguese community pharmacies in health care.

Félix J, Ferreira D, Afonso-Silva M, Gomes MV, Ferreira C, Vandewalle B, Marques S, Mota M, Costa S, Cary M, Teixeira I, Paulino E, Macedo B, Barbosa CM.

BMC Health Serv Res. 2017 Aug 29;17(1):606. doi: 10.1186/s12913-017-2525-4.

2.

EPICE-HIV: An Epidemiologic Cost-Effectiveness Model for HIV Treatment.

Vandewalle B, Llibre JM, Parienti JJ, Ustianowski A, Camacho R, Smith C, Miners A, Ferreira D, Félix J.

PLoS One. 2016 Feb 12;11(2):e0149007. doi: 10.1371/journal.pone.0149007. eCollection 2016.

3.

Cost-Effectiveness of Single- Versus Generic Multiple-Tablet Regimens for Treatment of HIV-1 Infection in the United States.

Sweet DE, Altice FL, Cohen CJ, Vandewalle B.

PLoS One. 2016 Jan 25;11(1):e0147821. doi: 10.1371/journal.pone.0147821. eCollection 2016.

4.

Pharmacoeconomics of ruxolitinib therapy in patients with myelofibrosis.

Vandewalle B, Andreozzi V, Almeida J, Félix J.

J Med Econ. 2016;19(4):424-31. doi: 10.3111/13696998.2015.1133430. Epub 2016 Jan 8.

PMID:
26743907
5.

Cost-Effectiveness of Lenalidomide-Plus-Dexamethasone in Multiple Myeloma Patients Who Have Received at Least One Prior Therapy: A South Korean Perspective.

Vandewalle B, Félix J, Almeida J, Valeska A, Yeo R.

Value Health. 2014 Nov;17(7):A736. doi: 10.1016/j.jval.2014.08.111. Epub 2014 Oct 26. No abstract available.

6.

Upfront Overall Survival Modelling in Comparison to Real World Data: Lenalidomide for the Treatment of Multiple Myeloma Patients in South Korea.

Félix J, Vandewalle B, Almeida J, Valeska A.

Value Health. 2014 Nov;17(7):A729. doi: 10.1016/j.jval.2014.08.073. Epub 2014 Oct 26. No abstract available.

7.

High Therapeutic Efficiency With Sofosbuvir For The Treatment Of Chronic Hepatitis C.

Félix J, Silva M, Ferreira D, Vandewalle B, Guerra I, Cure S, Aldir I, Carvalho A, Macedo G, Marinho RT, Pedroto I, Ramalho F.

Value Health. 2014 Nov;17(7):A371. doi: 10.1016/j.jval.2014.08.847. Epub 2014 Oct 26. No abstract available.

8.

Sofosbuvir For The Treatment Of Chronic Hepatitis C: A Comprehensive Cost-Effectiveness Analysis Across Hcv Genotypes, Pretreatment Conditions And Hiv Co-Infection.

Silva M, Félix J, Ferreira D, Vandewalle B, Guerra I, Cure S, Aldir I, Carvalho A, Macedo G, Marinho RT, Pedroto I, Ramalho F.

Value Health. 2014 Nov;17(7):A366. doi: 10.1016/j.jval.2014.08.820. Epub 2014 Oct 26. No abstract available.

9.

Cost-Effectiveness Of Linaclotide: A Valuable Option In The Treatment Of Irritable Bowel Syndrome.

Almeida J, Vandewalle B, Félix J.

Value Health. 2014 Nov;17(7):A366. doi: 10.1016/j.jval.2014.08.818. Epub 2014 Oct 26. No abstract available.

10.

Regulation and functional effects of ZNT8 in human pancreatic islets.

Lefebvre B, Vandewalle B, Balavoine AS, Queniat G, Moerman E, Vantyghem MC, Le Bacquer O, Gmyr V, Pawlowski V, Kerr-Conte J, Pattou F.

J Endocrinol. 2012 Aug;214(2):225-32. doi: 10.1530/JOE-12-0071. Epub 2012 May 11.

PMID:
22582094
11.

The nuclear orphan receptor Nur77 is a lipotoxicity sensor regulating glucose-induced insulin secretion in pancreatic β-cells.

Briand O, Helleboid-Chapman A, Ploton M, Hennuyer N, Carpentier R, Pattou F, Vandewalle B, Moerman E, Gmyr V, Kerr-Conte J, Eeckhoute J, Staels B, Lefebvre P.

Mol Endocrinol. 2012 Mar;26(3):399-413. doi: 10.1210/me.2011-1317. Epub 2012 Feb 2.

12.

The nuclear receptor FXR is expressed in pancreatic beta-cells and protects human islets from lipotoxicity.

Popescu IR, Helleboid-Chapman A, Lucas A, Vandewalle B, Dumont J, Bouchaert E, Derudas B, Kerr-Conte J, Caron S, Pattou F, Staels B.

FEBS Lett. 2010 Jul 2;584(13):2845-51. doi: 10.1016/j.febslet.2010.04.068. Epub 2010 May 4.

13.

Efficient gene delivery and silencing of mouse and human pancreatic islets.

Lefebvre B, Vandewalle B, Longue J, Moerman E, Lukowiak B, Gmyr V, Maedler K, Kerr-conte J, Pattou F.

BMC Biotechnol. 2010 Mar 30;10:28. doi: 10.1186/1472-6750-10-28.

14.

Upgrading pretransplant human islet culture technology requires human serum combined with media renewal.

Kerr-Conte J, Vandewalle B, Moerman E, Lukowiak B, Gmyr V, Arnalsteen L, Caiazzo R, Sterkers A, Hubert T, Vantyghem MC, Pattou F.

Transplantation. 2010 May 15;89(9):1154-60. doi: 10.1097/TP.0b013e3181d154ac.

PMID:
20098354
15.

5'-AZA induces Ngn3 expression and endocrine differentiation in the PANC-1 human ductal cell line.

Lefebvre B, Belaich S, Longue J, Vandewalle B, Oberholzer J, Gmyr V, Pattou F, Kerr-Conte J.

Biochem Biophys Res Commun. 2010 Jan 1;391(1):305-9. doi: 10.1016/j.bbrc.2009.11.054. Epub 2009 Nov 12.

PMID:
19913512
16.

PCSK9 is expressed in pancreatic delta-cells and does not alter insulin secretion.

Langhi C, Le May C, Gmyr V, Vandewalle B, Kerr-Conte J, Krempf M, Pattou F, Costet P, Cariou B.

Biochem Biophys Res Commun. 2009 Dec 25;390(4):1288-93. doi: 10.1016/j.bbrc.2009.10.138. Epub 2009 Oct 28.

PMID:
19878649
17.

Primary graft function, metabolic control, and graft survival after islet transplantation.

Vantyghem MC, Kerr-Conte J, Arnalsteen L, Sergent G, Defrance F, Gmyr V, Declerck N, Raverdy V, Vandewalle B, Pigny P, Noel C, Pattou F.

Diabetes Care. 2009 Aug;32(8):1473-8. doi: 10.2337/dc08-1685.

18.

Degradation of cAMP-responsive element-binding protein by the ubiquitin-proteasome pathway contributes to glucotoxicity in beta-cells and human pancreatic islets.

Costes S, Vandewalle B, Tourrel-Cuzin C, Broca C, Linck N, Bertrand G, Kerr-Conte J, Portha B, Pattou F, Bockaert J, Dalle S.

Diabetes. 2009 May;58(5):1105-15. doi: 10.2337/db08-0926. Epub 2009 Feb 17.

19.

Quantitative in vivo islet potency assay in normoglycemic nude mice correlates with primary graft function after clinical transplantation.

Caiazzo R, Gmyr V, Kremer B, Hubert T, Soudan B, Lukowiak B, Vandewalle B, Vantyghem MC, Pattou F, Kerr-Conte J.

Transplantation. 2008 Jul 27;86(2):360-3. doi: 10.1097/TP.0b013e31817ef846.

PMID:
18645503
20.

Acute insulin response to arginine in deceased donors predicts the outcome of human islet isolation.

Hubert T, Strecker G, Gmyr V, Arnalsteen L, Garrigue D, Ezzouaoui R, Caiazzo R, Dezfoulian G, Averland B, Vandewalle B, Vantyghem MC, Kerr-Conte J, Pattou F.

Am J Transplant. 2008 Apr;8(4):872-6. doi: 10.1111/j.1600-6143.2007.02131.x. Epub 2008 Feb 5.

21.

PPARgamma-dependent and -independent effects of rosiglitazone on lipotoxic human pancreatic islets.

Vandewalle B, Moerman E, Lefebvre B, Defrance F, Gmyr V, Lukowiak B, Kerr Conte J, Pattou F.

Biochem Biophys Res Commun. 2008 Feb 22;366(4):1096-101. Epub 2007 Dec 26.

PMID:
18155663
22.

In vivo and in vitro effect of sirolimus on insulin secretion.

Marcelli-Tourvieille S, Hubert T, Moerman E, Gmyr V, Kerr-Conte J, Nunes B, Dherbomez M, Vandewalle B, Pattou F, Vantyghem MC.

Transplantation. 2007 Mar 15;83(5):532-8.

PMID:
17353769
23.

Influence of preservation solution on human islet isolation outcome.

Hubert T, Gmyr V, Arnalsteen L, Jany T, Triponez F, Caiazzo R, Vandewalle B, Vantyghem MC, Kerr-Conte J, Pattou F.

Transplantation. 2007 Feb 15;83(3):270-6.

PMID:
17297400
24.

Glucotoxicity inhibits late steps of insulin exocytosis.

Dubois M, Vacher P, Roger B, Huyghe D, Vandewalle B, Kerr-Conte J, Pattou F, Moustaïd-Moussa N, Lang J.

Endocrinology. 2007 Apr;148(4):1605-14. Epub 2007 Jan 4.

PMID:
17204559
25.

In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion.

Chimienti F, Devergnas S, Pattou F, Schuit F, Garcia-Cuenca R, Vandewalle B, Kerr-Conte J, Van Lommel L, Grunwald D, Favier A, Seve M.

J Cell Sci. 2006 Oct 15;119(Pt 20):4199-206. Epub 2006 Sep 19.

26.

Peroxisome proliferator-activated receptor alpha improves pancreatic adaptation to insulin resistance in obese mice and reduces lipotoxicity in human islets.

Lalloyer F, Vandewalle B, Percevault F, Torpier G, Kerr-Conte J, Oosterveer M, Paumelle R, Fruchart JC, Kuipers F, Pattou F, Fiévet C, Staels B.

Diabetes. 2006 Jun;55(6):1605-13.

27.

1,25-Dihydroxyvitamin D3 protects human pancreatic islets against cytokine-induced apoptosis via down-regulation of the Fas receptor.

Riachy R, Vandewalle B, Moerman E, Belaich S, Lukowiak B, Gmyr V, Muharram G, Kerr Conte J, Pattou F.

Apoptosis. 2006 Feb;11(2):151-9.

PMID:
16502254
28.

Endocrine pancreatic tissue plasticity in obese humans is associated with cytoplasmic expression of PBX-1 in pancreatic ductal cells.

Muharram G, Beucher A, Moerman E, Belaïch S, Gmyr V, Vandewalle B, Pattou F, Kerr-Conte J.

Biochem Biophys Res Commun. 2005 Aug 12;333(4):1153-9.

PMID:
15979049
29.

Expression of progenitor cell markers during expansion of sorted human pancreatic beta cells.

Bouckenooghe T, Vandewalle B, Moerman E, Danzé PM, Lukowiak B, Muharram G, Kerr-Conte J, Gmyr V, Laine B, Pattou F.

Gene Expr. 2005;12(2):83-98.

30.

Rapid purification of human ductal cells from human pancreatic fractions with surface antibody CA19-9.

Gmyr V, Belaich S, Muharram G, Lukowiak B, Vandewalle B, Pattou F, Kerr-Conte J.

Biochem Biophys Res Commun. 2004 Jul 16;320(1):27-33.

PMID:
15207697
31.

Non-esterified fatty acids are deleterious for human pancreatic islet function at physiological glucose concentration.

Dubois M, Kerr-Conte J, Gmyr V, Bouckenooghe T, Muharram G, D'Herbomez M, Martin-Ponthieu A, Vantyghem MC, Vandewalle B, Pattou F.

Diabetologia. 2004 Mar;47(3):463-469. doi: 10.1007/s00125-004-1347-1. Epub 2004 Feb 13.

PMID:
14968298
32.

Kinetics of diabetes-associated autoantibodies after sequential intraportal islet allograft associated with kidney transplantation in type 1 diabetes.

Vantyghem MC, Fajardy I, Pigny P, Noel C, Kerr-Conte J, Gmyr V, Vandewalle B, Proye C, Pattou F.

Diabetes Metab. 2003 Dec;29(6):595-601.

PMID:
14707888
33.

Modulation of specific beta cell gene (re)expression during in vitro expansion of human pancreatic islet cells.

Bouckenooghe T, Vandewalle B, Lukowiak B, Kerr-Conte J, Belaïch S, Gmyr V, Dubois M, Riachy R, Pattou F.

Cell Transplant. 2003;12(7):799-807.

PMID:
14653626
34.

Hepatocyte nuclear factor 4 alpha isoforms originated from the P1 promoter are expressed in human pancreatic beta-cells and exhibit stronger transcriptional potentials than P2 promoter-driven isoforms.

Eeckhoute J, Moerman E, Bouckenooghe T, Lukoviak B, Pattou F, Formstecher P, Kerr-Conte J, Vandewalle B, Laine B.

Endocrinology. 2003 May;144(5):1686-94.

PMID:
12697672
35.

1,25-dihydroxyvitamin D3 protects RINm5F and human islet cells against cytokine-induced apoptosis: implication of the antiapoptotic protein A20.

Riachy R, Vandewalle B, Kerr Conte J, Moerman E, Sacchetti P, Lukowiak B, Gmyr V, Bouckenooghe T, Dubois M, Pattou F.

Endocrinology. 2002 Dec;143(12):4809-19.

PMID:
12446608
36.

[Human pancreatic stem cell and diabetes cell therapy].

Pattou F, Kerr-Conte J, Gmyr V, Vandewalle B, Vantyghem MC, Lecomte-Houcke M, Proye C, Lefebvre J.

Bull Acad Natl Med. 2000;184(9):1887-99; discussion 1899-901. Review. French.

PMID:
11471251
37.

Human pancreatic ductal cells: large-scale isolation and expansion.

Gmyr V, Kerr-Conte J, Vandewalle B, Proye C, Lefebvre J, Pattou F.

Cell Transplant. 2001 Jan-Feb;10(1):109-21.

PMID:
11294467
38.

Identification and purification of functional human beta-cells by a new specific zinc-fluorescent probe.

Lukowiak B, Vandewalle B, Riachy R, Kerr-Conte J, Gmyr V, Belaich S, Lefebvre J, Pattou F.

J Histochem Cytochem. 2001 Apr;49(4):519-28.

PMID:
11259455
39.

Beneficial effect of 1,25 dihydroxyvitamin D3 on cytokine-treated human pancreatic islets.

Riachy R, Vandewalle B, Belaich S, Kerr-Conte J, Gmyr V, Zerimech F, d'Herbomez M, Lefebvre J, Pattou F.

J Endocrinol. 2001 Apr;169(1):161-8.

PMID:
11250657
40.

Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in normal human pancreatic islet cells.

Dubois M, Pattou F, Kerr-Conte J, Gmyr V, Vandewalle B, Desreumaux P, Auwerx J, Schoonjans K, Lefebvre J.

Diabetologia. 2000 Sep;43(9):1165-9.

PMID:
11043863
41.

Adult human cytokeratin 19-positive cells reexpress insulin promoter factor 1 in vitro: further evidence for pluripotent pancreatic stem cells in humans.

Gmyr V, Kerr-Conte J, Belaich S, Vandewalle B, Leteurtre E, Vantyghem MC, Lecomte-Houcke M, Proye C, Lefebvre J, Pattou F.

Diabetes. 2000 Oct;49(10):1671-80.

PMID:
11016451
42.

Sequential intraportal islet allografts in immunosuppressed type I diabetic patients: preliminary results.

Pattou F, Vantyghem MC, Noel C, Kerr-Conte J, Gmyr V, Martinache I, Vandewalle B, N'Guyen H, Lecomte-Houcke M, Lefebvre J, Proye C.

Transplant Proc. 2000 Mar;32(2):391-2. No abstract available.

PMID:
10715450
43.

Human pancreatic islet quality control: easy assessment of metabolic functions.

Vandewalle B, Douillard C, Kerr Conte J, Gmyr V, Riachi R, D'herbomez M, Pattou F, Lefebvre J.

Exp Clin Endocrinol Diabetes. 1999;107(3):214-9.

PMID:
10376449
45.

Vitamin-D3 derivatives and breast-tumor cell growth: effect on intracellular calcium and apoptosis.

Vandewalle B, Hornez L, Wattez N, Revillion F, Lefebvre J.

Int J Cancer. 1995 Jun 9;61(6):806-11.

PMID:
7790115
46.
47.

1,25-dihydroxyvitamin D3 receptors in normal and malignant human colorectal tissues.

Vandewalle B, Adenis A, Hornez L, Revillion F, Lefebvre J.

Cancer Lett. 1994 Oct 28;86(1):67-73.

PMID:
7954357
48.

Effect of extracellular ATP on breast tumor cell growth, implication of intracellular calcium.

Vandewalle B, Hornez L, Revillion F, Lefebvre J.

Cancer Lett. 1994 Sep 30;85(1):47-54.

PMID:
7923101
50.

Effect of calcium on e-cadherin expression in breast-tumor cells.

Vandewalle B, Revillion F, Doutrelant P, Granier A, Lefebvre J.

Int J Oncol. 1994 Jan;4(1):181-5.

PMID:
21566910

Supplemental Content

Loading ...
Support Center